Muhammad Abdulraheem Salem
MSc Clinical Pharmacy, Queen's University Belfast, UK, BCPS
Clinical Pharmacist, internal medicine, Hamad General Hospital
Muhammad Abdulraheem Muhammad Salem is an Internal Medicine Clinical Pharmacist at Hamad Medical Corporation, Qatar. He graduated from Faculty of Pharmacy, Tanta University, Egypt, in 2006.
He is a Board-Certified Pharmacotherapy Specialist since 2011. Got MSc ClinPharm from Queen’s University, Belfast in 2017. Started his career at Children’s Cancer Hospital, Egypt, as a Clinical Pharmacist in 2007. Then joined HMC (2012) as a Pediatric Oncology Clinical Pharmacist till 2018, then Internal Medicine (2019-now). Special interests: Pharmacogenomics, drug-interactions, and clinical research. Got Mayo-Clinic’s (Pharmacogenomics for your practice) certificate (2022).
Multiple publications, as the first author, on drug-interactions and pharmacogenomics: v Warfarin-Rifampin-Gene-Interaction (WARIF-G): A Retrospective, Genetic, Case-Control Study. (2023). v Genetic Polymorphism Effect on Warfarin-Rifampin Interaction: A Case Report. (2021). v Lamotrigine-induced neutropenia after high-dose concomitant initiation with phenytoin. (2021). v Evaluation of vancomycin initial trough levels in children. (2020). v Poster presentation at the American Academy of Pediatrics conference (Florida, 2018).
